4-Aminophenol

CAS No. 123-30-8

4-Aminophenol( p-Aminophenol | para-Aminophenol | 4-hydroxyaniline | p-hydroxyaniline )

Catalog No. M19498 CAS No. 123-30-8

4-Aminophenol (or para-aminophenol or p-aminophenol) is the organic compound with the formula H2NC6H4OH. Typically available as a white powder it is commonly used as a developer in black-and-white film marketed under the name Rodinal.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Aminophenol
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Aminophenol (or para-aminophenol or p-aminophenol) is the organic compound with the formula H2NC6H4OH. Typically available as a white powder it is commonly used as a developer in black-and-white film marketed under the name Rodinal.
  • Description
    4-Aminophenol (or para-aminophenol or p-aminophenol) is the organic compound with the formula H2NC6H4OH. Typically available as a white powder it is commonly used as a developer in black-and-white film marketed under the name Rodinal.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    p-Aminophenol | para-Aminophenol | 4-hydroxyaniline | p-hydroxyaniline
  • Pathway
    Immunology/Inflammation
  • Target
    ROS
  • Recptor
    Free radical scavengers
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    123-30-8
  • Formula Weight
    109.13
  • Molecular Formula
    C6H7NO
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:>10 mM
  • SMILES
    NC1=CC=C(O)C=C1
  • Chemical Name
    4-Aminophenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Borges RS et al. Chem Biol Drug Des. 2013 Mar;81(3):414-9.
molnova catalog
related products
  • Medicarpin

    Medicarpin a legume phytoalexin acts as an estrogen receptor (ER) agonist can stimulate osteoblast differentiation likely via ERα2 promote achievement of peak bone mass and is devoid of uterine estrogenicity; in addition given its excellent oral bioavailability it can be potential osteogenic agent.

  • Zidesamtinib

    Zidesamtinib (NVL-520) is an orally active, selective, potent, and blood-brain-barrier-crossing inhibitor of ROS1 fusion and resistance mutations, inhibits ROS1 and ROS1 G2032R, and can be used in the study of non-small-cell lung cancer and solid tumors.

  • Ophiopogonin D(b)

    Ophiopogonin D(OPD) significantly inhibited the in vitro and in vivo growth of prostate cells via RIPK1 OPD may be developed as a potential anti-prostate cancer agent.